Illustrative concept image.
Purpose & realistic expectations
NAD+ participates in cellular energy transfer and enzyme reactions. Its biological importance has prompted research into ageing and metabolism. A plausible mechanism does not prove that an intravenous infusion improves health or lifespan in people.
Assessment & planning
A medical consultation must establish whether an infusion is justified and whether the proposed formulation meets local requirements. Product identity, alternatives, monitoring and consent need to be clear before proceeding.
Precautions & limitations
Human evidence for IV wellness outcomes remains limited. Findings from oral precursors cannot simply be transferred to IV NAD+. Injectable products introduce contamination and infusion risks. NAD+ administration is not offered here pending legal and clinical verification.
Availability & next steps
This page supports informed discussion and does not offer a product, procedure or research treatment. Clinical suitability and Egyptian regulatory status require product-specific verification.
Frequently asked questions
Is this available now?
This page supports informed discussion and does not offer a product, procedure or research treatment. Clinical suitability and Egyptian regulatory status require product-specific verification.
How is suitability decided?
A medical consultation must establish whether an infusion is justified and whether the proposed formulation meets local requirements. Product identity, alternatives, monitoring and consent need to be clear before proceeding.
References & further reading
FDA — Ingredients suitable for sterile compoundingContent prepared 15 November 2026. Formal medical review pending. No reviewer or approval is implied. This information supports, and does not replace, an individualized clinical consultation.